|
RAB33B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.446600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.101810E-01 |
| Normal-vs-Stage2 |
3.502400E-01 |
| Normal-vs-Stage3 |
4.000600E-01 |
| Normal-vs-Stage4 |
4.989800E-02 |
| Stage1-vs-Stage2 |
9.506600E-01 |
| Stage1-vs-Stage3 |
1.377530E-02 |
| Stage1-vs-Stage4 |
6.28529999999738E-05 |
| Stage2-vs-Stage3 |
1.467560E-01 |
| Stage2-vs-Stage4 |
3.601700E-02 |
| Stage3-vs-Stage4 |
3.334000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.970600E-01 |
| Normal-vs-AfricanAmerican |
9.539800E-02 |
| Normal-vs-Asian |
4.312400E-01 |
| Caucasian-vs-AfricanAmerican |
1.107750E-02 |
| Caucasian-vs-Asian |
6.870600E-01 |
| AfricanAmerican-vs-Asian |
1.321210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.558200E-01 |
| Normal-vs-Female |
8.937600E-01 |
| Male-vs-Female |
6.053400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.004400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.949960E-01 |
| Normal-vs-Age(61-80Yrs) |
7.883400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.333200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.031600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.414200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.935200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.466300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.376400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.644400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.020470E-02 |
| Normal-vs-Grade 2 |
2.939700E-02 |
| Normal-vs-Grade 3 |
7.712600E-01 |
| Normal-vs-Grade 4 |
1.594890E-04 |
| Grade 1-vs-Grade 2 |
3.709800E-01 |
| Grade 1-vs-Grade 3 |
6.224400E-03 |
| Grade 1-vs-Grade 4 |
2.18190000000895E-06 |
| Grade 2-vs-Grade 3 |
3.256200E-03 |
| Grade 2-vs-Grade 4 |
1.12889997350152E-09 |
| Grade 3-vs-Grade 4 |
3.86260000000416E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.596600E-04 |
| Normal-vs-ccB subtype |
1.024610E-01 |
| ccA subtype-vs-ccB subtype |
1.35259999867188E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.557600E-01 |
| Normal-vs-N1 |
1.838830E-01 |
| N0-vs-N1 |
2.780600E-01 |
|
|
